News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

January 25, 2024—Gore & Associates announced FDA approval for the Excluder thoracoabdominal branch endoprosthesis (TAMBE). The device is an off-the-shelf …

November 19, 2024—Xeltis recently announced that the FDA has granted Breakthrough Device designation for the company’s aXess vascular access conduit and that the first patient was …

The 2024 PAD Guideline Update: How It Affects Practice. The most significant changes from the previous guidelines, achieving buy-in and consensus, key trends, obstacles to achieving …

Appropriate confirmatory diagnostic imaging on an “intent-to-treat” basis prior to stenting is critical. A combination of multiplanar venography and intravascular ultrasound (IVUS) are gold …

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, …

October 15, 2024—Contego Medical announced FDA premarket approval of the company’s Neuroguard IEP system. The three-in-one carotid stenting system combines a high …

Deep Venous Disease Patient Advocacy. Moderator Suresh Vedantham, MD, asks Leslie Lake, Volunteer President of the National Blood Clot Alliance and bilateral PE survivor, about patient …

When imaging confirms the presence of a pulmonary embolism (PE), physicians must determine the best treatment approach for each patient by taking a balanced look at the efficacy and …

December 19, 2024—Contego Medical announced the first commercial procedures were performed with the company’s Neuroguard IEP system. According to Contego, Neuroguard …